Jialin Lv

828 total citations
37 papers, 469 citations indexed

About

Jialin Lv is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Jialin Lv has authored 37 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Materials Chemistry. Recurrent topics in Jialin Lv's work include Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jialin Lv is often cited by papers focused on Lung Cancer Treatments and Mutations (17 papers), Lung Cancer Research Studies (11 papers) and Lung Cancer Diagnosis and Treatment (7 papers). Jialin Lv collaborates with scholars based in China, Saint Kitts and Nevis and Mongolia. Jialin Lv's co-authors include Junwei Ye, Guiling Ning, Guangyao Wang, Ye Qi, Lei Shi, Ying Che, Siqi Zhang, Hao Lu, Xinjie Yang and Zhigao Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hazardous Materials and Journal of Cleaner Production.

In The Last Decade

Jialin Lv

33 papers receiving 461 citations

Peers

Jialin Lv
Jialin Lv
Citations per year, relative to Jialin Lv Jialin Lv (= 1×) peers R. Ganapathi Raman

Countries citing papers authored by Jialin Lv

Since Specialization
Citations

This map shows the geographic impact of Jialin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialin Lv more than expected).

Fields of papers citing papers by Jialin Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialin Lv. The network helps show where Jialin Lv may publish in the future.

Co-authorship network of co-authors of Jialin Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Jialin Lv. A scholar is included among the top collaborators of Jialin Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialin Lv. Jialin Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Zhaozhen, Hui Zhang, Quan Zhang, et al.. (2025). Prognostic Value of C-Reactive Protein-to-Lymphocyte Ratio in Combined Immunotherapy and Chemotherapy for Small Cell Lung Cancer. Journal of Inflammation Research. Volume 18. 9343–9353.
2.
Lv, Jialin, et al.. (2025). Branch chain engineering inorganic nanofiller to construct high-performance inorganic-organic hybrid membrane. Journal of Membrane Science. 733. 124353–124353. 1 indexed citations
4.
Lv, Jialin, et al.. (2024). Sandwich structure engineering for constructing proton exchange membranes with excellent stability and proton conductivity. Journal of Membrane Science. 717. 123601–123601. 3 indexed citations
5.
Xie, Kunpeng, Hao Wang, Jialin Lv, et al.. (2024). Hederagenin reduces Aβ-induced oxidative damage, decreases Aβ deposition, and promotes cell survival by the P13K/Akt signaling pathway. Journal of Leukocyte Biology. 117(2). 3 indexed citations
6.
Zhang, Hui, Yi Hu, Yan Wang, et al.. (2023). Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients. Frontiers in Oncology. 12. 942123–942123. 7 indexed citations
7.
Lv, Jialin, Siyuan Wei, Yuxuan Yao, et al.. (2023). Preparation of multi-layered microcapsule-shaped activated biomass carbon with ultrahigh surface area from bamboo parenchyma cells for energy storage and cationic dyes removal. Journal of Cleaner Production. 396. 136517–136517. 79 indexed citations
8.
9.
Qi, Shaolong, Haiyan Zhang, Xinyu Wang, et al.. (2021). Development of a NIR fluorescent probe for highly selective and sensitive detection of cysteine in living cells and in vivo. Talanta. 234. 122685–122685. 34 indexed citations
10.
Ma, Li, Ying Hu, Quan Zhang, et al.. (2021). Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs. Frontiers in Oncology. 11. 643199–643199. 12 indexed citations
11.
Yin, Jing, Jiaxi Lu, Lei Peng, et al.. (2021). Danggui-Shaoyao-San Improves Gut Microbia Dysbiosis and Hepatic Lipid Homeostasis in Fructose-Fed Rats. Frontiers in Pharmacology. 12. 671708–671708. 19 indexed citations
12.
Qi, Ye, Junwei Ye, Guangyao Wang, et al.. (2020). Temperature Feedback‐Controlled Photothermal/Photodynamic/Chemodynamic Combination Cancer Therapy Based on NaGdF4:Er,Yb@NaGdF4:Nd@Cu‐BIF Nanoassemblies. Advanced Healthcare Materials. 9(21). e2001205–e2001205. 25 indexed citations
13.
Wang, Pengli, et al.. (2020). Triterpenoids From Alisma Species: Phytochemistry, Structure Modification, and Bioactivities. Frontiers in Chemistry. 8. 363–363. 22 indexed citations
14.
Zhang, Xinyong, Jialin Lv, Na Qin, et al.. (2020). HER2 Exon 20 Insertion Mutations in Lung Adenocarcinoma: Case Series and Response to Pyrotinib. Frontiers in Oncology. 10. 1162–1162. 9 indexed citations
15.
Qi, Ye, Junwei Ye, Jialin Lv, et al.. (2019). In-situ synthesis of metal nanoparticles@metal−organic frameworks: Highly effective catalytic performance and synergistic antimicrobial activity. Journal of Hazardous Materials. 387. 121687–121687. 69 indexed citations
16.
Ma, Li, Jialin Lv, Yujie Dong, et al.. (2019). PD-L1 Expression and Its Regulation in Lung Adenocarcinoma with ALK Translocation. Interdisciplinary Sciences Computational Life Sciences. 11(2). 266–272. 21 indexed citations
17.
Zhang, Xinyong, Jialin Lv, Xi Li, et al.. (2019). Nivolumab-induced Thyroid Dysfunctions in Patients with Previously Treated Non-small Cell Lung Cancer. Interdisciplinary Sciences Computational Life Sciences. 11(2). 287–291. 1 indexed citations
18.
Yue, Wentao, Jinghui Wang, Xiaoting Zhao, et al.. (2016). Sequential measurements of serum matrix metalloproteinase 9 to monitor chemotherapy responses in patients with advanced non-small-cell lung cancer. OncoTargets and Therapy. 9. 3299–3299. 4 indexed citations
19.
Li, Xi, Na Qin, Jinghui Wang, et al.. (2015). [Clinical Observation of Icotinib Hydrochloride for Advanced Non-small Cell Lung Cancer Patients with EGFR Status Identified].. SHILAP Revista de lepidopterología. 18(12). 734–9. 6 indexed citations
20.
Qin, Na, Xinjie Yang, Quan Zhang, et al.. (2013). Efficacy of Icotinib treatment in patients with stage IIIb/IV non‐small cell lung cancer. Thoracic Cancer. 5(3). 243–249. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026